Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy
Source abstract
Abstract
T and B cells infiltration, and inducing the formation of tumor-located tertiary lymphoid structures. Consequently, the response rate of αPD-L1 immunotherapy was drastically promoted to efficiently prevent tumor metastasis and recurrence, causing 84.6 % distant tumor inhibition and complete suppression of tumor metastasis. In summary, this innovative approach not only enhances the therapeutic potential of COFs but also opens up new avenues for integrating microbial and nanotechnological strategies in cancer treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Cellular uptake of nanoparticles: journey inside the cell10.1039/C6CS00636A ↗
2. Cancer nanomedicine10.1038/s41568-022-00496-9 ↗
3. Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake
4. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
5. Engineering multienzyme-mimicking covalent organic frameworks as pyroptosis inducers for boosting antitumor immunity
6. Covalent organic framework-supported molecularly dispersed near-infrared dyes boost immunogenic phototherapy against tumors
7. Covalent organic frameworks: opportunities for rational materials design in cancer therapy
8. Covalent organic framework nanomedicines: biocompatibility for advanced nanocarriers and cancer theranostics applications
9. Etching bulk covalent organic frameworks into nanoparticles of uniform and controllable size by the molecular exchange etching method for sonodynamic and immune combination antitumor therapy
10. Porphyrin-based covalent organic framework nanoparticles for photoacoustic imaging-guided photodynamic and photothermal combination cancer therapy10.1016/j.biomaterials.2019.119459 ↗
11. ATP-responsive smart hydrogel releasing immune adjuvant synchronized with repeated chemotherapy or radiotherapy to boost antitumor immunity10.1002/adma.202007910 ↗
12. Porphyrin-based covalent organic framework for imaging-guided cancer combinatorial immuno-sonodynamic therapy10.1002/adfm.202207749 ↗
13. Nanomedicines for an enhanced immunogenic cell death-based cancer vaccination response10.1021/acs.accounts.3c00771 ↗
14. Magnetic covalent organic framework nanospheres-based miRNA biosensor for sensitive glioma detection
15. The FomA Porin from fusobacterium nucleatum is a toll-Like receptor 2 agonist with immune adjuvant activity10.1128/CVI.00236-12 ↗
16. Harnessing engineered immune cells and bacteria as drug carriers for cancer immunotherapy10.1021/acsnano.2c07607 ↗
17. An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier
18. Recent advances in the use of covalent organic frameworks as heterogenous photocatalysts in organic synthesis10.1002/adma.202209475 ↗
19. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy10.1038/s41467-023-41121-z ↗
20. Staggered stacking covalent organic frameworks for boosting cancer immunotherapy
21. Nanoscale covalent organic framework for combinatorial antitumor photodynamic and photothermal therapy10.1021/acsnano.9b06467 ↗
22. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses10.1038/s41587-023-01957-8 ↗
23. Engineered bacterial outer membrane vesicles as controllable two-way adaptors to activate macrophage phagocytosis for improved tumor immunotherapy10.1002/adma.202206200 ↗
24. Antibacterial fusobacterium nucleatum-mimicking nanomedicine to selectively eliminate tumor-colonized bacteria and enhance immunotherapy against colorectal cancer10.1002/adma.202306281 ↗
25. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
26. Phospholipid-inspired alkoxylation induces crystallization and cellular uptake of luminescent COF nanocarriers10.1016/j.biomaterials.2024.122503 ↗
27. A bioorthogonal system reveals antitumour immune function of pyroptosis10.1038/s41586-020-2079-1 ↗
28. Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway10.1016/j.apsb.2018.12.004 ↗
29. Mitochondria as multifaceted regulators of cell death10.1038/s41580-019-0173-8 ↗
30. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity10.1016/j.molcel.2021.09.003 ↗
31. Biomaterials elicit pyroptosis enhancing cancer immunotherapy
32. Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity10.1016/j.apsb.2022.02.024 ↗
33. Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines10.1126/scitranslmed.abc2816 ↗
34. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery10.1038/s41596-022-00713-7 ↗
35. A bioactive nanocomposite integrated specific TAMs target and synergistic TAMs repolarization for effective cancer immunotherapy
36. Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies10.20892/j.issn.2095-3941.2022.0049 ↗
37. Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
38. The multifaceted role of CD4 T cells in CD8 T cell memory10.1038/nri.2015.10 ↗
39. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome10.1038/s41571-022-00619-z ↗
40. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities10.1038/s41568-022-00466-1 ↗
41. Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment10.1021/acsnano.1c02103 ↗
42. Tertiary lymphoid structures improve immunotherapy and survival in melanoma10.1038/s41586-019-1914-8 ↗
43. Distinct metabolic requirements regulate B cell activation and germinal center responses10.1038/s41590-023-01540-y ↗
44. Distinct microbial and immune niches of the human colon10.1038/s41590-020-0602-z ↗
45. Synergistic brilliance: engineered bacteria and nanomedicine unite in cancer therapy
46. Bacterial extracellular vesicle applications in cancer immunotherapy
47. Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens10.1038/s41588-021-00778-2 ↗
48. Regulation and function of the PD-L1 checkpoint10.1016/j.immuni.2018.03.014 ↗
49. Cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal cancer phototheranostics10.1021/acsnano.8b04066 ↗
50. An erythrocyte membrane-camouflaged fluorescent covalent organic framework for starving/nitric oxide/immunotherapy of triple-negative breast cancer10.1039/D3SC02022C ↗